Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
British Journal of Cancer
|
October 10, 2013
High-risk features in radiation-associated breast angiosarcomas
S P D'Angelo, C R Antonescu, D Kuk, et al.
Sarcoma
|
June 18, 2016
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma
A N Shoushtari, J Landa, D Kuk, et al.
ESMO Open
|
March 21, 2026
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma
O O Babatunde, K Seier, G Schwartz, et al.
ESMO Open
|
July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
E Rosenbaum, K Seier, M Bradic, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
British Journal of Cancer
|
October 10, 2013
High-risk features in radiation-associated breast angiosarcomas
S P D'Angelo, C R Antonescu, D Kuk, et al.
Sarcoma
|
June 18, 2016
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma
A N Shoushtari, J Landa, D Kuk, et al.
ESMO Open
|
March 21, 2026
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma
O O Babatunde, K Seier, G Schwartz, et al.
ESMO Open
|
July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
E Rosenbaum, K Seier, M Bradic, et al.
Page
of 2